Request To Download Sample of This Strategic Report @ R&D budget for the development of drug has increased the demand of global preclinical contract organization (CRO). According to Servier Research ...

DOVER, DE, USA I6, 2024 I Brenig Therapeutics announced the initiation of the first-in-human clinical trial for BT-267, a best-in-class LRRK2 ...

A collaborative research group, including researchers from Nagoya City University, National Institutes of Natural Sciences, ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

A study reveals that gut bacteria impact tamoxifen’s effectiveness in breast cancer treatment. Certain bacterial enzymes enhance the drug's recycling into the bloodstream, improving its efficacy.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate ...

Tamoxifen is a common and important treatment to prevent breast cancer from recurring. A new study shows that variation in a patient's gut microbiome can impact how effective the treatment is.

The report "Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic ...

Enanta Pharmaceuticals Inc. has released preclinical pharmacokinetics (PK) data for EDP-514, a potent and selective class II core assembly modulator in phase I development for the oral treatment of ...